Cargando…
A multi-center, double-blind, randomized, placebo- and positive-controlled phase II clinical study of benvitimod for the treatment of atopic dermatitis
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106160/ https://www.ncbi.nlm.nih.gov/pubmed/36808115 http://dx.doi.org/10.1097/CM9.0000000000002489 |
| _version_ | 1785026367153242112 |
|---|---|
| author | Cai, Lin Zhao, Yan Zheng, Min Zhang, Furen Sun, Qing Liu, Quanzhong Hu, Jin Shen, Juan Zhang, Jianzhong |
| author_facet | Cai, Lin Zhao, Yan Zheng, Min Zhang, Furen Sun, Qing Liu, Quanzhong Hu, Jin Shen, Juan Zhang, Jianzhong |
| author_sort | Cai, Lin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10106160 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101061602023-04-17 A multi-center, double-blind, randomized, placebo- and positive-controlled phase II clinical study of benvitimod for the treatment of atopic dermatitis Cai, Lin Zhao, Yan Zheng, Min Zhang, Furen Sun, Qing Liu, Quanzhong Hu, Jin Shen, Juan Zhang, Jianzhong Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-01-20 2023-02-15 /pmc/articles/PMC10106160/ /pubmed/36808115 http://dx.doi.org/10.1097/CM9.0000000000002489 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Correspondence Cai, Lin Zhao, Yan Zheng, Min Zhang, Furen Sun, Qing Liu, Quanzhong Hu, Jin Shen, Juan Zhang, Jianzhong A multi-center, double-blind, randomized, placebo- and positive-controlled phase II clinical study of benvitimod for the treatment of atopic dermatitis |
| title | A multi-center, double-blind, randomized, placebo- and positive-controlled phase II clinical study of benvitimod for the treatment of atopic dermatitis |
| title_full | A multi-center, double-blind, randomized, placebo- and positive-controlled phase II clinical study of benvitimod for the treatment of atopic dermatitis |
| title_fullStr | A multi-center, double-blind, randomized, placebo- and positive-controlled phase II clinical study of benvitimod for the treatment of atopic dermatitis |
| title_full_unstemmed | A multi-center, double-blind, randomized, placebo- and positive-controlled phase II clinical study of benvitimod for the treatment of atopic dermatitis |
| title_short | A multi-center, double-blind, randomized, placebo- and positive-controlled phase II clinical study of benvitimod for the treatment of atopic dermatitis |
| title_sort | multi-center, double-blind, randomized, placebo- and positive-controlled phase ii clinical study of benvitimod for the treatment of atopic dermatitis |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106160/ https://www.ncbi.nlm.nih.gov/pubmed/36808115 http://dx.doi.org/10.1097/CM9.0000000000002489 |
| work_keys_str_mv | AT cailin amulticenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT zhaoyan amulticenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT zhengmin amulticenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT zhangfuren amulticenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT sunqing amulticenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT liuquanzhong amulticenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT hujin amulticenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT shenjuan amulticenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT zhangjianzhong amulticenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT cailin multicenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT zhaoyan multicenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT zhengmin multicenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT zhangfuren multicenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT sunqing multicenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT liuquanzhong multicenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT hujin multicenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT shenjuan multicenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis AT zhangjianzhong multicenterdoubleblindrandomizedplaceboandpositivecontrolledphaseiiclinicalstudyofbenvitimodforthetreatmentofatopicdermatitis |